Dr. Adam Buckholz, MD

Dr. Buckholz practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Buckholz's NPI, 1588026876, was assigned on March 24, 2016. Dr. Buckholz graduated from UVA School of Medicine in 2016. Dr. Buckholz holds New York license 293832.

Dr. Buckholz's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Buckholz's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Buckholz to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buckholz practices, 4 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Buckholz's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Buckholz is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Buckholz is licensed in New York.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver and upper GI endoscopy among the conditions Dr. Buckholz treats.

CMS data shows 169 Medicare services from Dr. Buckholz across 9 procedure codes in 2024, for 144 Medicare patients. Medicare paid $16,219 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Buckholz in 2024. The largest group is 65 to 74, with 80 patients. 72% of them have high cholesterol, and 67% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buckholz's median patient age at 60, with 50% women.

In 2024, Dr. Buckholz wrote 98 Medicare Part D claims for 44 patients. 84% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $3,615 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Buckholz for performance year 2024, reported through an alternative payment model (APM). Dr. Buckholz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buckholz as offering telehealth. CMS counts 24 procedures of colonoscopy by Dr. Buckholz, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Buckholz, published from 2020 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Liver Cirrhosis, Biopsy and COVID-19. Dr. Buckholz has published most often in Clin Liver Dis. Dr. Buckholz's most frequent co-authors are Brett Emerson Fortune, MD, Russell E. Rosenblatt and Gyorgy Baffy, MD.

CMS Open Payments shows 31 general payments to Dr. Buckholz from 12 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 59% of the total. Nonin Medical, Inc. paid the most, $1,030.

Dr. Buckholz graduated from UVA School of Medicine in 2016.

Dr. Buckholz is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.